Insider Transactions in Q1 2023 at Syros Pharmaceuticals, Inc. (SYRS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Eric R Olson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+20.05%
|
-
|
|
Mar 31
2023
|
Kristin Stephens Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+28.22%
|
-
|
|
Mar 31
2023
|
David Roth Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+20.06%
|
-
|
|
Mar 31
2023
|
Conley Chee President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Mar 31
2023
|
Jason Haas Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Mar 31
2023
|
Nancy A Simonian |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+7.38%
|
-
|